XELOX in the treatment of metastatic colorectal cancer and TIMP-1 as prognostic and predictive marker in patients treated with XELOX as first line treatment

Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

OriginalsprogEngelsk
ForlagSyddansk Universitet. Det Sundhedsvidenskabelige Fakultet
StatusUdgivet - 2010

Citationsformater